Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab‐ and ustekinumab‐treated patients with inflammatory bowel disease—a prospective multicentre cohort study

BACKGROUND: Few data are available on the effects of age and comorbidity on treatment outcomes of vedolizumab and ustekinumab in inflammatory bowel disease (IBD). AIMS: To evaluate the association between age and comorbidity with safety and effectiveness outcomes of vedolizumab and ustekinumab in IB...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Aliment Pharmacol Ther
Main Authors: Asscher, Vera E. R., Biemans, Vince B. C., Pierik, Marieke J., Dijkstra, Gerard, Löwenberg, Mark, van der Marel, Sander, de Boer, Nanne K. H., Bodelier, Alexander G. L., Jansen, Jeroen M., West, Rachel L., Haans, Jeoffrey J. L., van Dop, Willemijn A., Weersma, Rinse K., Hoentjen, Frank, Maljaars, P. W. Jeroen
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2020
Fag:
Efficacy and Safety of Biologics for Crohn's Disease
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7539998/
https://ncbi.nlm.nih.gov/pubmed/32901983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.16073
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker